Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, USA; Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Department of Ophthalmology, Weill Cornell Medical College, New York, New York, USA.
Surv Ophthalmol. 2018 Sep-Oct;63(5):618-637. doi: 10.1016/j.survophthal.2018.04.002. Epub 2018 Apr 19.
Retinopathy of prematurity (ROP) is a retinal vasoproliferative disease that affects premature infants. Despite improvements in neonatal care and management guidelines, ROP remains a leading cause of childhood blindness worldwide. Current screening guidelines are primarily based on two risk factors: birth weight and gestational age; however, many investigators have suggested other risk factors, including maternal factors, prenatal and perinatal factors, demographics, medical interventions, comorbidities of prematurity, nutrition, and genetic factors. We review the existing literature addressing various possible ROP risk factors. Although there have been contradictory reports, and the risk may vary between different populations, understanding ROP risk factors is essential to develop predictive models, to gain insights into pathophysiology of retinal vascular diseases and diseases of prematurity, and to determine future directions in management of and research in ROP.
早产儿视网膜病变(ROP)是一种影响早产儿的视网膜血管增生性疾病。尽管新生儿护理和管理指南有所改进,但 ROP 仍然是全球儿童失明的主要原因。目前的筛查指南主要基于两个风险因素:出生体重和胎龄;然而,许多研究人员提出了其他风险因素,包括母体因素、产前和围产期因素、人口统计学、医疗干预、早产儿合并症、营养和遗传因素。我们回顾了现有的文献,探讨了各种可能的 ROP 风险因素。尽管存在相互矛盾的报告,而且风险可能在不同人群之间有所不同,但了解 ROP 风险因素对于开发预测模型、深入了解视网膜血管疾病和早产儿疾病的病理生理学以及确定 ROP 管理和研究的未来方向至关重要。